Savara (SVRA) CFO exercises 580K options and sells 394K shares in Form 4
Rhea-AI Filing Summary
Savara Inc Chief Financial Officer David L. Lowrance reported a combined option exercise and share sale in Savara common stock. On June 22, 2026, he sold 394,528 shares in an open-market transaction at a weighted average price of $5.6813 per share, with sale prices ranging from $5.54 to $5.78. On the same date, he exercised stock options covering a total of 580,187 shares at exercise prices between $1.11 and $4.45 per share, and 185,659 shares were withheld to satisfy tax obligations. Following these transactions, Lowrance directly owned 536,032 shares of Savara common stock.
Positive
- None.
Negative
- None.
Insights
CFO exercised options, paid taxes in shares, and sold stock, a sizable but mixed-position move.
David L. Lowrance, Savara’s CFO, executed a classic exercise-and-sell pattern on June 22, 2026. He exercised options for 580,187 shares at strike prices between $1.11 and $4.45 while also using shares to cover tax obligations.
The filing shows open-market sales of 394,528 shares at a weighted average of $5.6813, with additional 185,659 shares disposed of for tax withholding. After these moves, he directly holds 536,032 shares, so a meaningful equity stake remains.
The combination of large option exercises and sales appears to be a liquidity and tax-management event rather than a pure directional bet. There is no reference to a Rule 10b5-1 trading plan in the excerpt, so the timing context is not specified here.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 75,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 129,350 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 56,937 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 218,750 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 87,650 | $0.00 | -- |
| Exercise | Common Stock | 75,000 | $1.59 | $119K |
| Tax Withholding | Common Stock | 21,682 | $5.50 | $119K |
| Exercise | Common Stock | 129,350 | $1.23 | $159K |
| Tax Withholding | Common Stock | 28,928 | $5.50 | $159K |
| Exercise | Common Stock | 56,937 | $1.11 | $63K |
| Tax Withholding | Common Stock | 11,491 | $5.50 | $63K |
| Exercise | Common Stock | 218,750 | $1.51 | $330K |
| Tax Withholding | Common Stock | 60,057 | $5.50 | $330K |
| Exercise | Common Stock | 12,500 | $4.45 | $56K |
| Tax Withholding | Common Stock | 10,114 | $5.50 | $56K |
| Exercise | Common Stock | 87,650 | $3.35 | $294K |
| Tax Withholding | Common Stock | 53,387 | $5.50 | $294K |
| Sale | Common Stock | 394,528 | $5.6813 | $2.24M |
Footnotes (1)
- The price is a weighted average sales price. The sale prices ranged from $5.54 to $5.78. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 16, 2020, subject to the reporting person's continued service with the Issuer. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 13, 2022, subject to the reporting person's continued service with the Issuer. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2023, subject to the reporting person's continued service with the Issuer. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer.